Fecal microbiota transplantation (FMT) is recommended treatment for recurrent Clostridium difficile infection (CDI). There is also increasing evidence that FMT is effective in severe and severe-complicated CDI and in averting CDI-related complications such as colectomy and mortality. The elderly population (age ≥65) is disproportionately affected by CDI and has worse outcomes compared to their younger counterparts. In this article, we explore the role of FMT in elderly patients with CDI and other gastrointestinal diseases. It may be reasonable to offer FMT earlier in the CDI disease course in older individuals, possibly after just the second recurrence and/or for the first episode of severe CDI to halt disease progression and prevent development of associated complications.
|Original language||English (US)|
|Number of pages||7|
|State||Published - Aug 2017|
ASJC Scopus subject areas